THERAVANCE BIOPHARMA INC's ticker is TBPH and the CUSIP is G8807B106. A total of 125 filers reported holding THERAVANCE BIOPHARMA INC in Q3 2022. The put-call ratio across all filers is 0.59 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,191 | -16.6% | 138 | 0.0% | 0.00% | – |
| Q2 2023 | $1,428 | -4.6% | 138 | 0.0% | 0.00% | – |
| Q1 2023 | $1,497 | -25.2% | 138 | 0.0% | 0.00% | – |
| Q4 2022 | $2,000 | +100.0% | 138 | 0.0% | 0.00% | – |
| Q3 2022 | $1,000 | 0.0% | 138 | 0.0% | 0.00% | – |
| Q2 2022 | $1,000 | 0.0% | 138 | 0.0% | 0.00% | – |
| Q1 2022 | $1,000 | -50.0% | 138 | 0.0% | 0.00% | – |
| Q4 2021 | $2,000 | +100.0% | 138 | 0.0% | 0.00% | – |
| Q3 2021 | $1,000 | -50.0% | 138 | 0.0% | 0.00% | – |
| Q2 2021 | $2,000 | -33.3% | 138 | 0.0% | 0.00% | – |
| Q1 2021 | $3,000 | -25.0% | 138 | -36.1% | 0.00% | – |
| Q4 2020 | $4,000 | +33.3% | 216 | 0.0% | 0.00% | – |
| Q3 2020 | $3,000 | -40.0% | 216 | -4.4% | 0.00% | – |
| Q2 2020 | $5,000 | 0.0% | 226 | 0.0% | 0.00% | – |
| Q1 2020 | $5,000 | – | 226 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Woodford Investment Management Ltd | 10,898,879 | $264,297,000 | 23.51% |
| Foundation Asset Management, LP | 399,537 | $9,689,000 | 3.59% |
| Cormorant Asset Management, LP | 1,300,000 | $31,525,000 | 2.35% |
| Baupost Group | 9,309,168 | $225,747,000 | 2.18% |
| Old West Investment Management, LLC | 109,320 | $2,651,000 | 1.53% |
| SENZAR ASSET MANAGEMENT, LLC | 187,856 | $4,555,000 | 1.44% |
| Chescapmanager LLC | 350,631 | $8,503,000 | 1.27% |
| Virtus ETF Advisers LLC | 32,989 | $800,000 | 0.69% |
| Rock Springs Capital Management LP | 652,600 | $15,826,000 | 0.68% |
| NJ State Employees Deferred Compensation Plan | 34,142 | $828,000 | 0.15% |